Likewise, miR-495-3p, which is downregulated in patients with coronary artery disease, targets chemokine (C-C motif) ligand 2 (CCL2) and reduces apoptosis by affecting the cleaved caspase-3 production in HUVECs, as demonstrated in vitro [75]. This evidence concerns the gene CCL2 and coronary artery disorder.